Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

Beijing Chest Hospital affiliated to Capital Medical University, Beijing

Harbin Chest Hospital, Harbin

Qingdao Chest Hospital, Qingdao

Changsha Central Hospital, Changsha

Anhui Chest Hospital, Hefei

Jiamusi Tumor Hospital, Jiamusi

Shandong public health clinical center, Shandong

Xi'an Chest Hospital, Xi'an

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang

Infectious Disease Hospital of Hulunbuir, Hulunbuir

The 8th Medical Center of Chinese Pla General Hospital, Beijing

Hunan Province Chest Hospital, Changsha

Chongqing Public Heath Treatment Center, Chongqing

Dalian Public Health Center, Dalian

Fuzhou Pulmonary Hospital of Fujian, Fuzhou

Guangzhou Chest Hospital, Guangzhou

Heilongjiang Province center for tuberculosis Control and Prevention, Haerbin

Second Affiliated Hospital of Hainan Medical University, Haikou

Hangzhou Red Cross Hospital, Hangzhou

Second People's Hospital of Hohhot, Hohhot

Jiamusi Infectious Disease Hospital, Jiamusi

Jilin Tuberculosis Hospital, Jilin

People's Hospital of Linyi, Linyi

Second Hospital of Nanjing, Nanjing

Fourth People's Hospital of Nanning, Nanning

Guangxi Chest Hospital, Nanning

National Medical Center for Infectious Disease, Shanghai

Affiliated Hospital of Shaoxing University, Shaoxing

Shenyang Chest Hospital, Shenyang

Shijiazhuang Fifth Hospital, Shijiazhuang

Tianjin Haihe Hospital, Tianjin

The 8th Affiliated Hospital of Xinjiang Medical University, Ürümqi

Second People's Hospital of Weifang, Weifang

Wuhan Institute For Tuberculosis Control, Wuhan

First Affiliated Hospital of Xiamen Medical University, Xiamen

Henan Provincial Chest Hospital, Zhengzhou

Affiliated Hospital of Zunyi Medical University, Zunyi

Hebei Chest Hospital, Shijiazhuang

Taiyuan Fourth People's Hospital, Taiyuan